JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jetté, L. P.
Right arrow Articles by Sinave, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jetté, L. P.
Right arrow Articles by Sinave, C.

Journal of Clinical Microbiology, April 1999, p. 1178-1181, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Use of an Oxacillin Disk Screening Test for Detection of Penicillin- and Ceftriaxone-Resistant Pneumococci

Louise P. Jetté1,* and Christian Sinave2

Laboratoire de Santé Publique du Québec, Sainte-Anne-de-Bellevue,1 and Département de Microbiologie et Infectiologie, Faculté de Médecine, Université de Sherbrooke,2 Québec, Canada

Received 20 July 1998/Returned for modification 16 October 1998/Accepted 11 December 1998

In a context of worldwide emergence of resistance among Streptococcus pneumoniae strains, early detection of strains with decreased susceptibility to beta -lactam antibiotics is important for clinicians. If the 1-µg oxacillin disk diffusion test is used as described by the National Committee for Clinical Laboratory Standards, no interpretation is available for strains showing zone sizes of <= 19 mm, and there is presently no disk diffusion test available for screening cephalosporin resistance. The zones obtained by the diffusion method by using the 1-µg oxacillin disk were compared with penicillin MICs for 1,116 clinical strains and with ceftriaxone MICs for 695 of these strains. Among the 342 strains with growth up to the 1-µg oxacillin disk margin, none were susceptible (MIC, <= 0.06 µg/ml), 62 had intermediate resistance (MIC, 0.12 to 1.0 µg/ml), and 280 were resistant (MIC, >= 2.0 µg/ml) to penicillin. For ceftriaxone, among 98 strains with no zone of inhibition in response to oxacillin, 68 had intermediate resistance (MIC, 1.0 µg/ml), and 22 were resistant (MIC, >= 2.0 µg/ml). To optimize the use of the disk diffusion method, we propose that the absence of a zone of inhibition around the 1-µg oxacillin disk be regarded as an indicator of nonsusceptibility to penicillin and ceftriaxone and recommend that such strains be reported as nonsusceptible to these antimicrobial agents, pending the results of a MIC quantitation method.


* Corresponding author. Mailing address: Laboratoire de Santé Publique du Québec, 20045 Chemin Sainte-Marie, Sainte-Anne-de-Bellevue (Québec) Canada H9X 3R5. Phone: (514) 457-2070. Fax: (514) 457-6346. E-mail: ljette{at}lspq.org.


Journal of Clinical Microbiology, April 1999, p. 1178-1181, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1999 by the American Society for Microbiology. All rights reserved.